The U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...

Lipocine (LPCN) announced that the FDA has recently informed sponsors of approved testosterone products about class-wide labeling changes. This ...

A bipartisan Senate bill dubbed the “Skinny Label, Big Savings Act” was introduced in January. The bill would expand the scope of protection ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

The FDA’s Oncologic Drugs Advisory Committee recently voted to narrow the label for checkpoint inhibitors Keytruda and Opdivo ...

Chemicals such as titanium dioxide and potassium bromate, whose safety has been debated, are allowed in foods in the United ...

Furosemide injection was previously approved to treat congestion from fluid buildup in adults with chronic heart failure.

Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...

The approval for the first-line treatment of esophageal squamous cell carcinoma comes shortly after a label expansion for the ...